Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
GRL0617
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/20/2021
2-Bromo-3-fluoro-N-[(1-methyl-1H-indol-3-yl)sulfonyl]benzamide
Potential treatment - theoretical effect Experimental Antiviral Feb/20/2021
MI-09
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/18/2021
MI-30
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/18/2021
(Recombinant) IL-3
Potential treatment - pre-clinical evidence Experimental Other treatment Feb/18/2021
[SARSHRC-PEG4]2-chol
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/17/2021
C2 (IgG)
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/15/2021
D12 (IgG)
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/15/2021
Inulin
Potential treatment - theoretical effect Experimental Antiviral Feb/15/2021
NBP11
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/14/2021
NBP10
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/14/2021
ABP18
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/14/2021
COV2-2381
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
COV2-2072
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
COV2-3025
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
COV2-2050
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
Ferritin-NP-RBD
Potential treatment - pre-clinical evidence Experimental Vaccine Feb/12/2021
P10
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
P8
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
P9
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021